Methods of treating an inflammatory-related disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9023885
APP PUB NO 20130178439A1
SERIAL NO

13791314

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to pharmaceutical compositions and methods of treating inflammatory-related diseases associated with pro-inflammatory cytokine expression and/or reduced expression of anti-inflammatory cytokines. The method typically comprises administration of one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, such as, Meisoindigo and NATURA. Preferably the pharmaceutical composition comprises one or more compounds selected from isoindigo, indigo, indirubin, or derivatives thereof, an anti-inflammatory agent, and a pharmaceutically acceptable carrier.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATROGEN THERAPEUTICS INTERNATIONAL INC315 E 68TH STREET NEW YORK NY 10021

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liu, Xiao Mei Flushing, US 9 55
McCarron,, Jr James P New York, US 8 932
Mencher, Simon K New York, US 13 980
Mo, Lian Palo Alto, US 12 67
Wang, Longgui Flushing, US 18 1006

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 5, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00